Ropes & Gray advised ImmunoGen, while Walder Wyss advised the funds managed by Pharmakon Advisors.ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into a term loan financing…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Pietro Martinoia
…
This content is for Standard 1 Year members only. LoginJoin Now